References

1. R B Sartor, “Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases,” American Journal of Gastroenterology, vol. 92, no. suppl 12, pp. 5S–11S, 1997.

   View at: Google Scholar

2. N Nieto, M I Torres, M I Fernandez et al., “Experimental ulcerative colitis impairs antioxidant defense system in rat intestine,” Digestive Diseases and Sciences, vol. 45, no. 9, pp. 1820–1827, 2000.

   View at: Publisher Site | Google Scholar

3. B E Wendland, E Aghdassi, C Tam et al., “Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease,” American Journal of Clinical Nutrition, vol. 74, no. 2, pp. 259–264, 2001.

   View at: Google Scholar

4. Y Murata, Y Ishiguro, J Itoh, A Munakata, and Y Yoshida, “The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis,” Journal of Gastroenterology, vol. 30, no. suppl 8, pp. 56–60, 1995.

   View at: Google Scholar

5. G Rogler and T Andus, “Cytokines in inflammatory bowel disease,” World Journal of Surgery, vol. 22, no. 4, pp. 382–389, 1998.

   View at: Publisher Site | Google Scholar

6. H-C Reinecker, M Steffen, T Witthoeft et al., “Enhanced secretion of tumour necrosis factor-$a$, IL-6, and IL-1$ß$ by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease,” Clinical and Experimental Immunology, vol. 94, no. 1, pp. 174–181, 1993.

   View at: Google Scholar

7. M F Neurath, I Fuss, M Pasparakis et al., “Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice,” European Journal of Immunology, vol. 27, no. 7, pp. 1743–1750, 1997.

   View at: Google Scholar

8. J W Larrick and S C Wright, “Cytotoxic mechanism of tumor necrosis factor-$\alpha$,” FASEB Journal, vol. 4, no. 14, pp. 3215–3223, 1990.

   View at: Google Scholar

9. P A Baeuerle and T Henkel, “Function and activation of NF-$\kappa$B in the immune system,” Annual Review of Immunology, vol. 12, pp. 141–179, 1994.

   View at: Google Scholar

10. S N Han and S N Meydani, “Antioxidants, cytokines, and influenza infection in aged mice and elderly humans,” Journal of Infectious Diseases, vol. 182, no. suppl 1, pp. S74–S80, 2000.

    View at: Publisher Site | Google Scholar

11. H S Oz, T S Chen, C J McClain, and W J de Villiers, “Antioxidants as novel therapy in a murine model of colitis,” Journal of Nutritional Biochemistry, vol. 16, no. 5, pp. 297–304, 2005.

    View at: Publisher Site | Google Scholar

12. E B Kurutas, A Cetinkaya, E Bulbuloglu, and B Kantarceken, “Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis,” Mediators of Inflammation, vol. 2005, no. 6, pp. 390–394, 2005.

    View at: Publisher Site | Google Scholar

13. A S Jr Baldwin, “Series introduction: the transcription factor NF-$\kappa$B and human disease,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 3–6, 2001.

    View at: Google Scholar

14. G Rogler, K Brand, D Vogl et al., “Nuclear factor $?$B is activated in macrophages and epithelial cells of inflamed intestinal mucosa,” Gastroenterology, vol. 115, no. 2, pp. 357–369, 1998.

    View at: Publisher Site | Google Scholar

15. R Joshi, S Kumar, M Unnikrishnan, and T Mukherjee, “Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity,” Free Radical Research, vol. 39, no. 11, pp. 1163–1172, 2005.

    View at: Publisher Site | Google Scholar

16. N Auphan, J A DiDonato, C Rosette, A Helmberg, and M Karin, “Immunosuppression by glucocorticoids: inhibition of N NF-$\kappa$B activity through induction of IkB synthesis,” Science, vol. 270, no. 5234, pp. 286–290, 1995.

    View at: Google Scholar

17. M Pehlivan, Y Dalbeler, S Hazinedaroglu et al., “An assessment of the effect of Ginkgo biloba egb 761 on ischemia reperfusion injury of intestine,” Hepato-Gastroenterology, vol. 49, no. 43, pp. 201–204, 2002.

    View at: Google Scholar

18. I Maitra, L Marcocci, M T Droy-Lefaix, and L Packer, “Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761,” Biochemical Pharmacology, vol. 49, no. 11, pp. 1649–1655, 1995.

    View at: Publisher Site | Google Scholar

19. C Kusmic, G Basta, G Lazzerini, N Vesentini, and R Barsacchi, “The effect of Ginkgo biloba in isolated ischemic/reperfused rat heart: a link between vitamin E preservation and prostaglandin biosynthesis,” Journal of Cardiovascular Pharmacology, vol. 44, no. 3, pp. 356–362, 2004.

    View at: Publisher Site | Google Scholar

20. N Zeybek, S Gorgulu, G Yagci et al., “The effects of gingko biloba extract (EGb 761) on experimental acute pancreatitis,” Journal of Surgical Research, vol. 115, no. 2, pp. 286–293, 2003.

    View at: Publisher Site | Google Scholar

21. G P Morris, P L Beck, M S Herridge, W T Depew, M R Szewczuk, and J L Wallace, “Hapten-induced model of chronic inflammation and ulceration in the rat colon,” Gastroenterology, vol. 96, no. 3, pp. 795–803, 1989.

    View at: Google Scholar

22. Q Mei, J-P Yu, J-M Xu, W Wei, L Xiang, and L Yue, “Melatonin reduces colon immunological injury in rats by regulating activity of macrophages,” Acta Pharmacologica Sinica, vol. 23, no. 10, pp. 882–886, 2002.

    View at: Google Scholar

23. Y Huang, K R Johnson, J S Norris, and W Fan, “Nuclear factor-$\kappa$B/I$\kappa$B signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumors cells,” Cancer Research, vol. 60, no. 16, pp. 4426–4432, 2000.

    View at: Google Scholar

24. M F Neurath, S Pettersson, K-H Meyer zum Buschenfelde, and W Strober, “Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-$\kappa$B abrogates established experimental colitis in mice,” Nature Medicine, vol. 2, no. 9, pp. 998–1004, 1996.

    View at: Publisher Site | Google Scholar

25. F Girgin, O Karaoglu, M Erkus et al., “Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis,” Journal of Toxicology and Environmental Health - Part A, vol. 59, no. 8, pp. 641–652, 2000.

    View at: Publisher Site | Google Scholar

26. H W Verspaget, A S Pena, I T Weterman, and C BHW Lamers, “Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content,” Gut, vol. 29, no. 2, pp. 223–228, 1988.

    View at: Google Scholar

27. J Segui, F Gil, M Gironella et al., “Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis,” Inflammatory Bowel Diseases, vol. 11, no. 10, pp. 872–882, 2005.

    View at: Publisher Site | Google Scholar

28. F Kuralay, C Yildiz, O Ozutemiz et al., “Effects of trimetazidine on acetic acid-induced colitis in female swiss rats,” Journal of Toxicology and Environmental Health - Part A, vol. 66, no. 2, pp. 169–179, 2003.

    View at: Publisher Site | Google Scholar

29. A Sakarcan, O Sehirli, A Velioglu-Ovunc et al., “Ginkgo biloba extract improves oxidative organ damage in a rat model of thermal trauma,” Journal of Burn Care and Rehabilitation, vol. 26, no. 6, pp. 515–524, 2005.

    View at: Publisher Site | Google Scholar

30. S-Q Liu, J-P Yu, H-L Chen, H-S Luo, S-M Chen, and H-G Yu, “Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats,” American Journal of Chinese Medicine, vol. 34, no. 1, pp. 99–114, 2006.

    View at: Publisher Site | Google Scholar

31. T Cruz, J Galvez, M A Ocete, M E Crespo, L-H F Sanchez de Medina, and A Zarzuelo, “Oral administration of rutoside can ameliorate inflammatory bowel disease in rats,” Life Sciences, vol. 62, no. 7, pp. 687–695, 1998.

    View at: Publisher Site | Google Scholar

32. S Gossart, C Cambon, C Orfila, and M.-H Seguelas, “Reactive oxygen intermediates as regulators of TNF-$\alpha$ production in rat lung inflammation induced by silica,” Journal of Immunology, vol. 156, no. 4, pp. 1540–1548, 1996.

    View at: Google Scholar

33. A Mustafa, A El-Medany, H H Hagar, and G El-Medany, “Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis,” Pharmacological Research, vol. 53, no. 4, pp. 324–330, 2006.

    View at: Publisher Site | Google Scholar

34. I Ilieva, K Ohgami, K Shiratori et al., “The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo,” Experimental Eye Research, vol. 79, no. 2, pp. 181–187, 2004.

    View at: Publisher Site | Google Scholar

35. N Li and M Karin, “Is NF-$\kappa$B the sensor of oxidative stress?” FASEB Journal, vol. 13, no. 10, pp. 1137–1143, 1999.

    View at: Google Scholar

36. C K Sen and L Packer, “Antioxidant and redox regulation of gene transcription,” FASEB Journal, vol. 10, no. 7, pp. 709–720, 1996.

    View at: Google Scholar

37. R Schreck, P Rieber, and P A Baeuerle, “Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-$\kappa$B transcription factor and HIV-1,” EMBO Journal, vol. 10, no. 8, pp. 2247–2258, 1991.

    View at: Google Scholar

38. Z Wei, Q Peng, B HS Lau, and V Shah, “Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor $\kappa$ B in vascular endothelial cells,” General Pharmacology, vol. 33, no. 5, pp. 369–375, 1999.

    View at: Publisher Site | Google Scholar

39. J-W Chen, Y-H Chen, F-Y Lin, Y-L Chen, and S-J Lin, “Ginkgo biloba extract inhibits tumor necrosis factor-$\alpha$-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1559–1566, 2003.

    View at: Publisher Site | Google Scholar

40. S Videla, A Garcia-Lafuente, M Antolin et al., “Antitumor necrosis factor therapy in rat chronic granulomatous colitis: critical dose-timing effects on outcome,” Journal of Pharmacology and Experimental Therapeutics, vol. 287, no. 3, pp. 854–859, 1998.

    View at: Google Scholar

41. M Yamamoto, K Yoshizaki, T Kishimoto, and H Ito, “IL-6 is required for the development of Th1 cell-mediated murine colitis,” Journal of Immunology, vol. 164, no. 9, pp. 4878–4882, 2000.

    View at: Google Scholar

42. S-M Cheng, S-P Yang, L-J Ho et al., “Down-regulation of c-jun N-terminal kinase-activator protein-1 signaling pathway by Ginkgo biloba extract in human peripheral blood T cells,” Biochemical Pharmacology, vol. 66, no. 4, pp. 679–689, 2003.

    View at: Publisher Site | Google Scholar